OptiBiotix Health plc (AIM: OPTI) – further contract signed with NIZO Food Research
10/03/2015 · OptiBiotix Health PLC (OPTI)
We reported on OptiBiotix last week, it is a very exciting new business operating in one of the most progressive areas of biotechnological research. It aims to develop compounds which modify the human microbiome to help combat obesity, diabetes and high cholesterol.
Using its technology platforms for microbiome modulation, the Group has generated three research programmes which they are developing in the functional foods and health supplements marketplace.
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREEDON'T MISS OUT ON OUR PREMIUM CONTENT
Become a champion investor for just £90 a year. Benefit from our high performing portfolios:
- Ultimate Stocks
- Income Boosters
- Mega Tends
- Bonkers Bargains
- Stonking Small Caps
- IHT qualifying selections
- ...and more